Prof. Dr. Ljudmila Stojanovich, MD, PhD, FRCP, is a prominent specialist in autoimmune rheumatic diseases, focusing on Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), and vaccination in autoimmune patients. She earned her Ph.D. in 1999 with a thesis on neuropsychiatric manifestations in SLE. Prof. Stojanovich has published over 250 scientific papers and three monographs, contributing extensively to autoimmune disease research. She serves on the editorial boards of leading journals, including Lupus (London) and The Journal of Rheumatology, and is Associate Editor for Frontiers in Medicine and Frontiers in Immunology. She is involved in international research collaborations, such as EULAR initiatives on vaccination and APS management. Prof. Stojanovich has been a speaker, chair, and organizer at numerous international conferences, including the 12th European Forum on Antiphospholipid Antibodies. Her work has earned her an h-index of 36 and over 5,000 citations, reflecting her global impact in rheumatology.

Dr. Weronika Dardzińska, PhD, DVM is a pharmacovigilance and clinical-development leader with 15 years of global experience in drug safety science, AI driven data review and front line patientcare. She has deep therapeutic expertise in oncology (NSCLC, multiplemyeloma) and respiratory disease (COPD, asthma), gained through safety roles at GSK, MSD and TFS. Weronika pairs her doctorate with postgraduate training in epidemiology, biostatistics, computational biopharmacy and pharmacoeconomics/HTA, weaving real world evidence and population models into drug-safety decision making. Her current research interest lies in translating advanced analytics into measurable improvements in patient quality of life and outcomes.